Jump to main content
Jump to site search


Syntheses and anti-cancer activity of CO-releasing molecules with targeting galactose receptors

Author affiliations

Abstract

CO-releasing molecules (CORMs) containing cobalt have many bioactivities, but most of them do not dissolve in water and have no selectivity to tissue and organs. On the basis of the specific recognition of galactose or sialic acid by a receptor, a series of CORMs based on carbohydrates were synthesized and evaluated. The test results show that all the complexes displayed anticancer activity. Among them, the effects of the complexes of galactose (1), GalNAc (8) and sialic acid (10) were very distinct. Complex 1 displayed higher activity against HeLa, HePG2, MCF-7 and HT-29 cell proliferation than cis-platin (DDP), and its selectivity was far much better than DDP compared with normal cell W138. Furthermore, the uptakes of complexes 1, 8 and 10 by HePG2, HT-29, A549 and RAW264.7 cell lines were studied. The uptake ratio of each cell line for complex 1 was different, and the order of uptake ratio in the four cell lines was HePG2 > HT-29 > RAW264.7 > A549. The HePG2 cells absorbed complex 1 beyond 60% after incubation for 8 h, while A549 absorbed only 27.8%. For complex 8, the uptake trend was similar to that of complex 1 with it being absorbed by all the four cancer cells, but the uptake rate was lower. However, differently, complex 10 was absorbed heavily by macrophage RAW264.7, followed by HePG2; after 8 h incubation, the uptake ratio of RAW264.7 was over 50%. In addition, the mechanism of action was explored, and the results showed that the complexes inhibited cell cycle arrest at the G2/M phase; complex 1 up-regulated the expression levels of caspase-3 and Bax, and down-regulated the Bcl-2 expression, giving rise to HePG2 cell apoptosis.

Graphical abstract: Syntheses and anti-cancer activity of CO-releasing molecules with targeting galactose receptors

Back to tab navigation

Supplementary files

Publication details

The article was received on 07 Aug 2018, accepted on 09 Oct 2018 and first published on 09 Oct 2018


Article type: Paper
DOI: 10.1039/C8OB01921E
Citation: Org. Biomol. Chem., 2018, Advance Article
  •   Request permissions

    Syntheses and anti-cancer activity of CO-releasing molecules with targeting galactose receptors

    J. Li, J. Zhang, Q. Zhang, Z. Bai, Q. Zhao, D. He, Z. Wang, Y. Chen and B. Liu, Org. Biomol. Chem., 2018, Advance Article , DOI: 10.1039/C8OB01921E

Search articles by author

Spotlight

Advertisements